e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Enhancement of nucleoside cytotoxicity through nucleotide prodrugs
…, H Someya, SC Shaddix, JA Montgomery…
Index: Rose, Jerry D.; Parker, William B.; Someya, Hitoshi; Shaddix, Sue C.; Montgomery, John A.; Secrist III, John A. Journal of Medicinal Chemistry, 2002 , vol. 45, # 20 p. 4505 - 4512
A common reason for the lack of cytotoxicity of certain nucleosides is thought to be their inability to be initially activated to the monophosphate level by a nucleoside kinase or other activating enzyme. In a search for other nucleosides that might be worthwhile anticancer agents, we have begun to examine the utilization of monophosphate prodrugs in order to explore whether any enhanced cytotoxicity might be found for the prodrugs of candidate ...